BASF plans world-scale ibuprofen plant in Germany, expands in USA
BASF said Wednsesday it plans to build a new world-scale plant to produce ibuprofen in Ludwigshafen, Germany.
Pharmaceuticals, Biotechnology and Life Sciences
BASF said Wednsesday it plans to build a new world-scale plant to produce ibuprofen in Ludwigshafen, Germany.
In a daily briefing, Daily Stock Tracker (DST) gave some insight on certain biotech stocks, noting that the global Pharmaceutical industry is dominated by the American and European markets. According to Forbes’ top companies of 2017, the ten biggest drug companies are all located in these two regions.
Arix Bioscience has raised $45 million by a Series B financing round for LogicBio Therapeutics, a new Arix Group Business focused on gene therapies for orphan paediatric diseases.
Vivace Therapeutics, an oncology-focused portfolio-based drug discovery and development company is coming out of stealth with $40 million raised in Series A and B financings.
Janssen Research & Development, said Wednesday the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for Xarelto (rivaroxaban).
Roche’s new tablet for treating certain types of idiopathic pulmonary fibrosis (IPF) was approved by the European Commission, the Swiss drugmaker announced on Tuesday.
Jury selection in the New York trial of former drug company executive Martin Shkreli will enter its third day Wednesday, after some potential jurors said they could not be fair to a man who gained notoriety by raising the price of a life-saving drug more than 5,000 percent.
Novartis ahs won European clerance for Erelzi, as the European Commission approved it for Novartis’s division Sandoz.
A recent survey on the state of label management in the pharmaceutical industry undertaken by NiceLabel in cooperation with Pharmaceutical Manufacturing reveals the challenges facing pharmaceutical manufacturers as they try to produce accurate, compliant labels, and highlights the increasing importance of a single, integrated label management system.
An exclusive License and Supply Agreement (LSA) has been signed between Fuji Pharma, the leader in women’s health in Japan, and Mithra, a Euronext -listed company specialized in women’s health, for the commercialization of Donesta in Japan and ASEAN territories.